Ion-Exchange Kinetics of Alpha-Zirconium Phosphate Nanoplatelets for Application in Targeted Alpha Therapy

Jeffrey D. Einkauf, Luis H. Ortega, Sean M. McDeavitt, Jonathan D. Burns

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The loading and kinetics of uptake for the inorganic ion-exchange material, α-zirconium phosphate, Zr(HPO4)2•H2O, were investigated with ions relevant to targeted alpha therapy including natural Cs+ (as a surrogate for 221Fr), natural Bi3+ (as a surrogate for 213Bi), and natural La3+ (as a surrogate for 225Ac). The narrow interlayer spacing of the α-phase (d = 7.6 Å) was found not to be advantageous with respect to rapid ion exchange, while converting the material to the hydrated Na-phase (d = 12.2 Å) allowed ion exchange to proceed more quickly, reaching equilibrium in under an hour. High loading was achieved for all three ions, at 72 ± 4% for Cs+ and 95 ± 5% for La3+ at pH 3 and 108 ± 10% for Bi3+ at pH 0.5. Leaching profiles of the loaded materials in a simulated human plasma environment of 10 mM carbonate buffer at pH 7.4 and 37°C, showed negligible release, with less than 1% in all cases. The ion-exchange properties and overall benign nature of zirconium phosphate highlight these materials as a promising platform for a targeted alpha therapy drug-delivery vehicle.

Original languageEnglish
Pages (from-to)612-628
Number of pages17
JournalSolvent Extraction and Ion Exchange
Volume38
Issue number6
DOIs
StatePublished - Sep 18 2020

Funding

The DRUV-Vis and PXRD analysis made use of equipment funded under the U.S. Department of Energy, Nuclear Energy University Program Grant #DE-NE0008653 and #DE-NE0008740, respectively, for which the authors are grateful. Use of the TAMU Materials Characterization Facility is acknowledged for SEM-EDS measurements.

Keywords

  • Ion-exchange
  • alpha zirconium phosphate
  • targeted alpha therapy

Fingerprint

Dive into the research topics of 'Ion-Exchange Kinetics of Alpha-Zirconium Phosphate Nanoplatelets for Application in Targeted Alpha Therapy'. Together they form a unique fingerprint.

Cite this